Latest Biotechnology Industry News | Page 6

Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
New ESG guide seeks industry feedback
Dr Robert Lin named named new CEO of GreenLight Clinical
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
Best early-stage project at awarded at AusMedtech 2023
Pharmaxis reports positive results from trial of PXS‐6302
CSIRO launches free SME programme
Oncosil Medical announces first patient treatment in Italy
Victorian-based digital health companies selected for inaugural ANDHealth ACTIVATE program
Silverstone receives approval for advanced life sciences facility in Brisbane
Avecho Biotechnology commences manufacturing for Phase 3 insomnia study
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
Merck backing indigenous communities in creating a new approach to STEM skills
Chimeric Therapeutics announces new capital raise
New report calls on national cell and gene therapy plan
Federal 2023-24 Budget wrap up for biotech
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
LBT Innovations begins search for new board chair
Antisense Therapeutics announces the appointment of new CEO and managing director
Telix to supply Bayer with Illuccix for global late-stage prostate cancer study
FDA removes clinical hold on Immuron’s new campylobacter ETEC therapeutic
Patent granted in India and Notice of Allowance Issued in Israel for CLTX Car Technology
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Opportunity to invest in Australian biotech companies
New approval for trial of Immutep’s ‘efti’ with Merck’s PD-L1 inhibitor
Cytiva supports BioCina with first GMP production and development facility for mRNA
Find and be found: Utilising free global life sciences Directory
Telix reports its first quarter of $100 million in revenue
Major milestone for Australian pharmaceutical company, Neuren
Regulatory changes for medical device clinical trials not needed
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Assessors needed for industry PhD program
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
Pharmaxis adds combination arm to PXS‐5505 myelofibrosis study
Focus turns to all things medtech
Immutep announces changes to its board of directors
Recce Pharmaceuticals announces planned grant of ‘Patent Family 4’ for anti-infectives
ATSE seek views on commercialisation
Emyria and Aspen Australia sign binding licensing and commercialisation term sheet
Pitch your early-stage medtech
Industry groups welcome Senate backing of National Reconstruction Fund
IDT achieves milestone with TGA-approved expansion of manufacturing
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
AusMedtech goes back to future
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
Directory of Australian accelerators and incubators launched
Brandon BioCatalyst with ANDHealth to deliver BioMedTech Incubator Program
Support for passage of NRF legislation through Senate